Global Aeromonas Hydrophila Nucleic Acid Detection Kit Market Size By Type (Dry PCR, Fluorescence PCR), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Aeromonas Hydrophila Nucleic Acid Detection Kit Market was valued at USD 112.4 million in 2023 and is projected to reach USD 197.6 million by 2031, growing at a CAGR of 7.3% during the forecast period of 2023–2031. The increasing prevalence of waterborne diseases, rising concerns over aquatic food safety, and the growing demand for rapid and accurate pathogen detection are key factors fueling market growth. Aeromonas hydrophila is a significant pathogen in aquaculture and can cause serious infections in both humans and animals. As such, nucleic acid detection kits play a critical role in monitoring and mitigating the spread of this bacterium, particularly in the food industry, environmental monitoring, and clinical diagnostics.

Drivers:

1. Growing Incidence of Aquatic Pathogens:

With the rise in aquaculture production and environmental contamination, the incidence of Aeromonas-related infections is increasing, driving the need for reliable diagnostic tools.

2. Advancements in Molecular Diagnostics:

Innovations in PCR, RT-PCR, and isothermal amplification techniques are enhancing the speed, sensitivity, and specificity of nucleic acid detection kits, making them indispensable in modern diagnostics.

3. Regulatory Push for Food Safety:

Stricter food safety regulations and quality control measures across the globe are prompting food producers and water treatment facilities to adopt Aeromonas detection kits for compliance and prevention.

Restraints:

1. High Cost of Advanced Kits:

The cost of high-performance molecular diagnostic kits can be prohibitive for small labs and resource-constrained regions, limiting their widespread adoption.

2. Limited Awareness in Developing Regions:

In several emerging markets, there is a lack of awareness and limited diagnostic infrastructure, which hampers the adoption of nucleic acid detection technologies.

Opportunity:

1. Expansion in Aquaculture and Water Quality Monitoring:

Rapid expansion in fish farming and growing concerns about water quality present significant opportunities for the widespread use of Aeromonas hydrophila detection kits.

2. Integration with Portable and Point-of-Care Devices:

The development of compact and field-deployable detection systems integrated with these kits will broaden their application in on-site diagnostics and environmental testing.

Market by System Type Insights:

Based on system type, Real-Time PCR Kits accounted for the largest market share in 2023. These kits are preferred for their high sensitivity, specificity, and real-time monitoring capabilities, making them ideal for both laboratory and field settings. The LAMP-based (Loop-Mediated Isothermal Amplification) Kits segment is projected to grow at the fastest pace, favored for their simplicity, speed, and minimal equipment requirements.

Market by End-use Insights:

The Aquaculture Industry emerged as the dominant end-use segment in 2023, holding over 40% of the market share. The rising demand for safe and disease-free fish products is encouraging farmers to adopt proactive pathogen monitoring. The Environmental Testing segment is also expanding, driven by regulatory mandates and the need for sustainable water management solutions.

Market by Regional Insights:

Asia-Pacific led the global market in 2023, driven by the region’s large aquaculture industry, increasing government regulations, and high incidence of Aeromonas outbreaks in countries like China and India. North America is expected to witness robust growth during the forecast period due to heightened awareness of waterborne pathogens and advancements in diagnostic technologies.

Competitive Scenario:

Key players in the Global Aeromonas Hydrophila Nucleic Acid Detection Kit Market include Bio-Rad Laboratories, QIAGEN, Thermo Fisher Scientific, NEB (New England Biolabs), Merck KGaA, Promega Corporation, and Eurofins Technologies. Companies are focusing on expanding their molecular diagnostics portfolio, forming distribution alliances, and innovating rapid detection platforms.

Scope of Work – Global Aeromonas Hydrophila Nucleic Acid Detection Kit Market

Report Metric Details

Market Size (2023) USD 112.4 million

Projected Market Size (2031) USD 197.6 million

CAGR (2023–2031) 7.3%

Market Segments System Type (Real-Time PCR Kits, LAMP Kits), End-Use (Aquaculture, Environmental Testing, Clinical Diagnostics), Region

Growth Drivers Rising aquaculture demand, stricter food safety standards, innovations in nucleic acid diagnostics

Opportunities Integration with point-of-care tools, increased demand in emerging economies

Key Market Developments:

2023: QIAGEN launched a new real-time PCR kit targeting aquatic pathogens including Aeromonas hydrophila, tailored for on-site testing in aquaculture environments.

2024: Bio-Rad Laboratories announced a partnership with a Southeast Asian aquaculture group to supply customized detection kits for microbial screening.

2025: Thermo Fisher introduced a multiplex PCR platform compatible with Aeromonas detection assays, enabling simultaneous detection of multiple pathogens.

FAQs:

What is the current market size of the Global Aeromonas Hydrophila Nucleic Acid Detection Kit Market?

The market size in 2023 was USD 112.4 million.

What is the major growth driver of the Global Aeromonas Hydrophila Nucleic Acid Detection Kit Market?

The primary driver is the rising incidence of aquatic pathogens and growing demand for accurate pathogen detection in aquaculture and water quality testing.

Which is the largest region during the forecast period in the Global Aeromonas Hydrophila Nucleic Acid Detection Kit Market?

Asia-Pacific is the largest and fastest-growing regional market due to widespread aquaculture operations and increasing regulatory oversight.

Which segment accounted for the largest market share in Global Aeromonas Hydrophila Nucleic Acid Detection Kit Market?

The Real-Time PCR Kits segment held the largest share in 2023.

Who are the key market players in the Global Aeromonas Hydrophila Nucleic Acid Detection Kit Market?

Key players include Bio-Rad Laboratories, QIAGEN, Thermo Fisher Scientific, Merck KGaA, and Eurofins Technologies.